Trophoblastic Disease

  • Y. Tomoda
  • T. Ishizuka
  • S. Goto
  • Y. Furuhashi
Part of the Current Topics in Pathology book series (CT PATHOLOGY, volume 85)


Trophoblastic disease originates from the placental villi and possesses the following features:
  1. 1.

    The paternal genes are inherited, and from the standpoint of graft immunity the disease has the characteristics of a homograft tumor.

  2. 2.

    These tumors produce human chorionic gonadotropin (hCG), and the level of hCG is a valuable marker for diagnosis as well as for assessment of therapeutic effect and remission.

  3. 3.

    Chemotherapy is very effective, and even metastatic cases may be cured by chemotherapy alone.

  4. 4.

    The tumors apparently progress from hydatidiform mole to invasive mole to choriocarcinoma, and therfore by controlling the hydatidiform mole stage it is possible to detect early choriocarcinoma or even prevent its occurrence.



Pulmonary Metastasis Trophoblastic Cell Hydatidiform Mole Gestational Trophoblastic Disease Intracranial Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Acosta-Sison H (1967) Trophoblastic or chorionic tumors as observed in the Philippines. In: Holland JF, Hreshchyshyn MM (eds) Choriocarcinoma. Springer, Heidelberg Berlin New York, ( UICC Monograph Series, vol 3, pp 33–36 )Google Scholar
  2. Athanassiou A, Begent RHG, Newlands Es, Parker D, Rustin GJS, Bagshawe KD (1983) Central nervous system metastases of choriocarcinoma-23 years’ experience at Charing Cross Hospital. Cancer 52: 1728–1735PubMedCrossRefGoogle Scholar
  3. Bagshawe KD (1969) Metastatic Choriocarcinoma. In: Choriocarcinoma. Edward Arnold, London, pp 93–103Google Scholar
  4. Bagshawe KD (1977) Treatment of trophoblastic tumors. Recent Results Cancer Res 62: 192–199PubMedGoogle Scholar
  5. Bagshawe KD (1987) Chemotherapy and general treatment—current and future developments. In: Takagi S, Freidberg V, Haller U, Knapstein PG, Sevin BV (eds) Gynecologic oncology, surgery and urology. Central Foreign Books, Tokyo, pp 243–249Google Scholar
  6. Bagshawe KD, Dent J, Webb J (1986) Hydatidiform mole in England and Wales 1973–1983. Lancet 1I: 673–677CrossRefGoogle Scholar
  7. Bahn RS, Worsham A, Speeg KV, Ascoli M, Rabin D (1981) Characterization of steroid production in cultured human choriocarcinoma cells. J Clin Endocrinol Metab 52: 447–450PubMedCrossRefGoogle Scholar
  8. Brindley CJ, Antoniw P, Newlands ES, Bagshawe KD (1985) Pharmacokinetics and toxicity of the epipodophyllotoxin derivative etoposide in patients with gestational choriocarcinoma and malignant teratoma. Cancer Chemother Pharmacol 15: 66–71PubMedCrossRefGoogle Scholar
  9. Franke HR, Risse EKJ, Kenemans P, Vooijs GR, Stolk JG (1983) Epidemiologic features of hydatidiform mole in the Netherlands. Obsestet Gynecol 62: 613–616Google Scholar
  10. Goldstein DP (1972) The chemotherapy of gestational trophoblastic disease. JAMA 220: 209–213PubMedCrossRefGoogle Scholar
  11. Hammond CB, Borchert LG, Tyrey L, Creasman WT, Parker RT (1973) Treatment of metastatic trophoblastic disease: good and poor progonosis. Am J Obstet Gynecol 115: 451–457PubMedGoogle Scholar
  12. Hammond CB, Weed JC, Currie JL (1980) The role of operation in the current therapy of gestational trophoblastic disease. Am J Obstet Gynecol 136: 844–858PubMedGoogle Scholar
  13. Hara T, Kaseki S, Tomoda Y, Nishikawa Y, Ishizuka T, Ishizuka N (1986) Determinants of risk for developing invasive mole and choriocarcinoma following hydatidiform mole. Asia Oceania J Obstet Gynecol 12: 241–250CrossRefGoogle Scholar
  14. Hertz R (1967) Eight years experience with the chemotherapy of choriocarcinoma and related trophoblastic tumors in women. In: Holland JF, Hreshchyshyn MM (eds) Choriocarcinoma. Springer, Heidelberg Berlin New York (UICC Monograph Series, vol 3, pp 66–71 )Google Scholar
  15. Hertz R, Bergenstal DM, Lipsett MB, Price EB, Hilbish TF (1958) Chemotherapy of choriocarcinoma and related trophoblastic tumors in women. JAMA 168: 845–854CrossRefGoogle Scholar
  16. Hertz R, Ross GT, Lipsett MB (1963) Primary chemotherapy of nonmetastatic trophoblastic disease in women. Am J Obstet Gynecol 86: 808–814PubMedGoogle Scholar
  17. Hirokawa K, Tomoda Y, Kaseki S, Ishizuka T, Nishikawa Y, Goto S (1986) Recurrence of invasive moles and choriocarcinomas. Asia Oceania J Obstet Gynecol 12: 11–20CrossRefGoogle Scholar
  18. Ishizuka N (1976) Studies on trophoblastic neoplasia. In: Hirayama T (ed) Cancer in Asia. University of Tokyo Press, Tokyo (Gann Monograph on Cancer Research No 18, pp 203–216 )Google Scholar
  19. Izhizuka T, Tomoda Y, Kaseki S, Goto S, Hara T, Kobayashi T (1983) Intracranial metastasis of choriocarcinoma—a clinicopathologic study. Cancer 52: 1896–1903CrossRefGoogle Scholar
  20. Jacobs PA, Hassold TJ, Matsuyama AM, Newland IM (1978) Chromosome constitutions of gestational trophoblastic disease. Lancet II: 49Google Scholar
  21. Kajii T, Ohama K (1977) Androgenetic origin of hydatidiform moles. Nature 286: 633–634CrossRefGoogle Scholar
  22. Kaseki S (1974) Primary chemotherapy of trophoblastic disease—experience with 123 cases. Acta Obstet Gynecol Jpn 26: 1069–1076Google Scholar
  23. Kolstad P, Hognestad J (1965) Trophoblastic tumors in Norway. Acta Obstet Gynecol Scand 44: 80–88PubMedCrossRefGoogle Scholar
  24. Kurman RJ, Young RH, Norris HJ, Main CS, Lawrence WD, Scully R (1984) Immunocytochemical localization of placental lactogen and chorionic gonadotropin in the normal placenta and trophoblastic tumors, with emphasis on intermediate trophoblast and the placental site trophoblastic tumor. Int J Gynecol Pathol 3: 101–121PubMedCrossRefGoogle Scholar
  25. Lawler SD, Pickthall VJ, Fisher RA, Povey S, Evans MW, Szulman AE (1979) Genetic studies of complete and partial hydatidiform moles. Lancet 11: 580CrossRefGoogle Scholar
  26. Li MC, Hertz R, Spencer DB (1956) Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc Soc Exp Biol Med 93: 361–366PubMedGoogle Scholar
  27. Llewellyn-Jones D (1965) Trophoblastic tumors—geographical variations in incidence and possible aetiological factors. J Obstet Gynecol Br Commonw 72: 242–248CrossRefGoogle Scholar
  28. Lurain JR, Brewer JI, Trok EE, Halpern B (1983) Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol 145: 591–595PubMedGoogle Scholar
  29. McCorriston CC (1968) Racial incidence of hydatidiform mole. Am J Obstet Gynecol 101:377–382 Newlands ES (1982) New chemotherapeutic agents in the management of gestational choriocarcinoma. Semin Oncol 9: 239–243Google Scholar
  30. Newlands ES, Bagshawe KD (1979) Activity of high-dose cisplatinum in combination with vincristine and methotrexate in drug-resistant gestational choriocarcinoma. A report of 17 cases. Br J Cancer 40: 943–945PubMedCrossRefGoogle Scholar
  31. Newlands ES, Bagshawe KD (1980) Anti-tumor activity of the epipodophyllin derivative VP16–213 in gestational choriocarcinoma. Eur J Cancer 16: 401–405PubMedGoogle Scholar
  32. Nishikawa Y, Kaseki S, Tomoda Y, Ishizuka T, Asai Y, Suzuki T, Ushijima H (1985) Histopathologic classification of uterine choriocarcinoma. Cancer 55: 1044–1051PubMedCrossRefGoogle Scholar
  33. Ohama K, Kajii T, Okamoto E et al. (1981) Dispermic origin of XY moles. Nature 292: 551–552PubMedCrossRefGoogle Scholar
  34. Park WW, Lees JC: Choriocarcinoma. A general review, with an analysis of 516 cases. Arch Path 49:73–104, 205–241 (1950)Google Scholar
  35. Registration Committee for Trophoblastic Disease of the Japan Society of Obstetrics and Gynecology (1982) Report of the Registration Committee for Trophoblastic Disease. Acta Obstet Gynecol Jpn 34: 1805–1812Google Scholar
  36. Registration Committee for Trophoblastic Disease of the Japan Society of Obstetrics and Gynecology (1987) Report of the Registration Committee for Trophoblastic Disease. Acta Obstet Gynecol Jpn 39: 871–880Google Scholar
  37. Report of a WHO scientific group (1983) Gestational trophoblastic disease. WHO technical report series 692, Geneva, pp 11–12Google Scholar
  38. Report on the study financially assisted by the Cancer Research Fund of the Ministry of Health and Welfare for the fiscal year 1980Google Scholar
  39. Ringertz N (1970) Hydatidiform mole, invasive mole and choriocarcinoma in Sweden. Acta Obstet Gynecol Scand 49: 195–203PubMedCrossRefGoogle Scholar
  40. Ross GT, Stolbach LL, Hertz R (1962) Actinomycin D in the treatment of methotrexate-resistant trophoblastic disease in women. Cancer Res 22: 1015–1017PubMedGoogle Scholar
  41. Shirley RL, Goldstein DP, Collins JJ (1972) The role of thoracotomy in the management of patients with chest metastases from gestational metastatic disease. J Thorac Cardiovasc Surg 63: 545–550PubMedGoogle Scholar
  42. Sugiura M, Goto S, Saito M, Kato S, Hattori S, Tomoda Y (1988) Establishment and characterization of three new human gestational choriocarcinoma cell lines. Acta Obstet Gynecol Jpn 40: 1447–1454Google Scholar
  43. Sung HC, Wu PC, Hu MH, Su HT (1982) Roentgenologic manifestations of pulmonary metastases in choriocarcinoma and invasive mole. Am J Obstet Gynecol 142: 89–92PubMedGoogle Scholar
  44. Teoh ES, Dawood MY, Ratnam SS (1971) Epidemiology of hydatidiform mole in Singapore. Am J Obstet Gynecol: 415–420Google Scholar
  45. Thomford NR, Woolner LB, Clagett OT (1965) The surgical treatment of metastatic tumors in the lungs. J Thorac Cardiovasc Surg 49: 357–363PubMedGoogle Scholar
  46. Tomoda Y, Kaseki S, Goto S, Ishizuka T, Furuhashi Y, Kato S (1986) Approach for attaining complete cure of trophoblastic disease. In: Ichinoe K (ed) Trophoblastic disease. Igaku-Shoin, Tokyo, pp 111–120Google Scholar
  47. Wake N, Takagi N, Sasaki M (1978) Androgenesis as a cause of hydatidiform mole. JNCI 60: 51–57PubMedGoogle Scholar
  48. Weed JC, Hammond CB (1980) Cerebral metastatic choriocarcinoma: intensive therapy and prognosis. Obstet Gynecol 55: 89–94PubMedGoogle Scholar
  49. Xu LT, Sun CF, Wang YE, Song HZ (1985) Resection of pulmonary metastatic choriocarcinoma in 43 drug-resistant patients. Ann Thorac Surg 39: 257–259PubMedCrossRefGoogle Scholar
  50. Yamashita K, Wake N, Araki T, Ichinoe K, Kuroda M (1979) Human lymphocyte antigen expression in hydatidiform mole: androgenesis following fertilization by a haploid sperm. Am J Obstet Gynecol 135: 597–600PubMedGoogle Scholar
  51. Yen S, MacMahon B (1968) Epidemiologic features of trophoblastic disease. Am J Obstet Gynecol 101: 126–132PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • Y. Tomoda
  • T. Ishizuka
  • S. Goto
  • Y. Furuhashi

There are no affiliations available

Personalised recommendations